Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Photo: Jabin Botsford/The Washington Post via Getty Images
President Trump and his friends have received coronavirus antibody treatments that are so scarce that some states and hospitals are giving them out via a lottery system, the New York Times reports.
Why it matters: Putting aside questions of medical ethics, these high-profile examples of successful coronavirus recoveries could give the impression that the virus is much less dangerous than it is — particularly because most patients won't have access to the same game-changing treatment that these politicians did.
- Recipients, in addition to Trump himself, include Ben Carson, Chris Christie and Rudy Giuliani.
What they're saying: "If it wasn't me, I wouldn't have been put in a hospital frankly," Giuliani told WABC radio. "Sometimes when you're a celebrity, they're worried if something happens to you they’re going to examine it more carefully, and do everything right."
- "Mr. Giuliani's candid admission once again exposes that Covid-19 has become a disease of the haves and the have-nots," NYT writes.
The big picture: The antibody therapies, developed by Eli Lilly and Regeneron, received authorization from the Food and Drug Administration last month to be used by high-risk patients with "mild to moderate" disease.
- That means a lot of patients who are diagnosed with the virus could qualify.
- Health and Human Services Secretary Alex Azar said yesterday that 278,000 doses of the two therapies have been allocated. 210,000 coronavirus cases were reported just yesterday.